B型钠尿肽对合并左室舒张功能不全的血液透析患者的诊断价值被引量：2

导出

摘要目的探讨B型钠尿肽对合并左室舒张功能不全的血液透析患者的诊断价值。方法检测40例维持性血液透析患者的血浆BNP浓度,用超声心动图将40例患者分为舒张功能不全组与心功能正常组,并测定20例健康患者血浆BNP浓度作为对照组。结果维持性血透患者血浆BNP伴有舒张功能不全组及不伴有舒张功能不全组均高于健康对照组(P<0.05);伴有舒张功能不全组在-4h、0h、48hBNP均高于不伴有舒张功能不全组(P<0.05);透析后即刻(0h)比透析前(-4h)BNP升高(P<0.05);下次透析前(48h)比本次透析前(-4h)BNP下降(P<0.05)。结论透析患者血浆BNP明显升高,合并舒张功能不全的血透患者BNP高于不合并左室舒张功能不全的血透患者,BNP的测定对早期发现血透患者舒张功能不全有一定的价值。

作者路长刘芳

机构地区杭州市第三人民医院肾内科天津市第三中心医院

出处《中国现代医生》 2011年第13期130-131,共2页 China Modern Doctor

关键词 BNP 血液透析舒张功能不全

分类号 R692.3 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献7

1Bettencourt P,Ferreira A,Dias P,et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure[J]. Cardiology,2000,93 (1):19-25.
2李松松,刘克强,张东玲.脑钠肽对左室舒张功能不全诊断价值的研究[J].天津医药,2008,36(1):26-28. 被引量：18
3刘婧,孙倩美.脑钠肽与慢性肾脏病患者心血管疾病关系的研究进展[J].中国血液净化,2008,7(1):38-41. 被引量：30
4王凉,孙铸兴.BNP在终末期肾病透析患者中心功能的诊断价值[J].中国血液净化,2004,3(5):276-278. 被引量：8
5C Zeng,T Wei,L Jin. Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients[J]. Internal Medicine Journal,2006,36:552-557.
6Takase H,Dohi Y,Toriyama T,et al. B-type natriuretic peptid elevels and cardiovascular risk in patients with diastolic dysfunction on chronic haemodialysis: cross-sectional and observational studies [J]. Nephrol Dial Transplant, 2010, 12: 408.
7Victoria S,Vikas B,Alisi T,et al. The use of B-type natriuretic peptide to assess volume status in patients with ESRD[J]. Am Heard J,2007,153:244.

二级参考文献71

1周文彦,倪兆慧,方炜,顾乐怡,王琴,牟姗,曹励欧,俞赞喆,钱家麒.慢性肾脏病非透析患者脑钠素与动脉粥样硬化及心功能的关系[J].中华肾脏病杂志,2007,23(3):162-166. 被引量：21
2[1]Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family.Lancet, 1997,349 : 1307 - 1310
3[2]Luchner A, Stevens TL, Borgeson DD, et al. Different atrial and ventriculur expression of myocardial BNP during evolution of heart failure.46th Annual Scientific Session of America College of Cardiology, 1998,H1684 - H1689
4[3]Mair J, Lercher AH, Puschendort B. The impact of cardiac natriuretic peptides determination on the diagnosis and management of heart failure.Clin Chem Lab, 2001,39(7) 571 -588
5[4]Stingo AJ, Clavell AL, Heublein DM, et al. Presence ofC - type natriuretic peptides in cultured human endothelial cells and plasma. Am J Physiol, 1992, 235:561 - 576
6[5]Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptide are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol, 2001,12:1508- 1515
7[6]Kohs KP, Feifel K, Mayer Wehrstain R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol,1993,40:83 - 90
8[7]McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptonmatic left vantricular systolic dysfunction in an urban population.Lancet, 1997, 350: 829 - 833
9[8]Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substady of the studies of left veatricular dysfunction (SOLVD). Circulation, 1990, 82:1724 - 1729
10[9]Struthers. Prospects for using a blood sample in the diagnosis of heart failure Q J Med, 1995, 88:303 - 306